Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

May 31, 2003

Conditions
Cancer
Interventions
DRUG

liposomal amphotericin B

Trial Locations (24)

1000

Institut Jules Bordet, Brussels

1070

Hopital Universitaire Erasme, Brussels

1097

Szent Laszlo Korhaz, Budapest

1100

Hospital De Santo Antonio Dos Capuchos, Lisbon (Lisboa)

5530

Clinique Universitaire De Mont-Godinne, Mont-Godinne Yvoir

8000

A.Z. St. Jan, Bruges

11527

Athens University-Laikon General Hospital, Athens

14033

CHU de Caen, Caen

16132

Istituto Nazionale per la Ricerca sul Cancro, Genoa (Genova)

33006

Hospital Central de Asturias, Oviedo

54642

Hippokration Hospital, Thessaloniki

75475

Hopital Saint-Louis, Paris

91120

Hadassah University Hospital, Jerusalem

94010

Centre Hospitalier Universitaire Henri Mondor, Créteil

B-3000

U.Z. Gasthuisberg, Leuven

775 20

University Hospital - Olomouc, Olomouc

D-10117

Universitaetsklinikum Charite, Berlin

D-13353

Virchow Klinikum Humboldt Universitaet Berlin, Berlin

NL-6500 HB

University Medical Center Nijmegen, Nijmegen

812 50

National Cancer Institute - Bratislava, Bratislava

08025

Hospital de la Santa Cruz I Sant Pau, Barcelona

SE-141 86

Huddinge University Hospital, Stockholm

06100

Section of Infectious Diseases, Ankara

Unknown

Tawam Hospital, Abu Dhabi

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00003938 - Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients | Biotech Hunter | Biotech Hunter